|
|
||||||||
1 Department of Medicine, Lund University, SE-205 02 Malmö, Sweden; and 2 Department of Endocrinology and Metabolism, Panum Institute, Copenhagen DK-2200, Denmark
Pituitary adenylate cyclase-activating polypeptide (PACAP) is localized to pancreatic ganglia governing the parasympathetic nerves, which contribute to prandial insulin secretion. We hypothesized that this contribution involves PACAP and show here that the PACAP receptor antagonist PACAP-(6---27) (1.5 nmol/kg iv) reduces the 15-min insulin response to gastric glucose (150 mg/mouse) by 18% in anesthetized mice (P = 0.041). The reduced insulinemia was not due to inhibited release of the incretin factor glucagon-like peptide 1 (GLP-1) because PACAP-(6---27) enhanced the GLP-1 response to gastric glucose. Furthermore, the GLP-1 antagonist exendin-3-(9---39) (30 nmol/kg) exerted additive inhibitory effect on the insulin response when combined with PACAP-(6---27). The PACAP antagonism was specific because intravenous PACAP-(6---27) inhibited the insulin response to intravenous PACAP-27 plus glucose without affecting the insulin response to intravenous glucose alone (1 g/kg) or glucose together with other insulin secretagogues of potential incretin relevance of intestinal (GLP-1, gastric inhibitory polypeptide, cholecystokinin) and neural (vasoactive intestinal peptide, gastrin-releasing peptide, cholinergic agonism) origin. We conclude that PACAP contributes to the insulin response to gastric glucose in mice and suggest that PACAP is involved in the regulation of prandial insulin secretion.
pituitary adenylate cyclase-activating polypeptide; antagonism; glucagon-like peptide 1; exendin; glucose tolerance
This article has been cited by other articles:
![]() |
O. Skott Pituitary adenylate cyclase-activating polypeptide and adrenomedullary function Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R586 - R587. [Full Text] [PDF] |
||||
![]() |
K. Filipsson, M. Kvist-Reimer, and B. Ahren The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide and Islet Function Diabetes, September 1, 2001; 50(9): 1959 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakagawa, S. Azuma, and H. Nakabayashi Novel gastroinsular axis involving a gastric transmural glucose flux and vagal mediation Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E304 - E314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ahrén and J. J. Holst The Cephalic Insulin Response to Meal Ingestion in Humans Is Dependent on Both Cholinergic and Noncholinergic Mechanisms and Is Important for Postprandial Glycemia Diabetes, May 1, 2001; 50(5): 1030 - 1038. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |